ATYR

aTyr Pharma
ATYR

Overview Fund Trends Analyst Outlook Journalist POV

36 hedge funds and large institutions have $53.1M invested in aTyr Pharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

49% less capital invested

Capital invested by funds: $105M → $53.1M (-$51.9M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

85% less call options, than puts

Call options by funds: $64K | Put options by funds: $436K

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$64K
Puts
$436K
Net Calls
Net Calls Change

Top Buyers

1
+$599K
2
+$466K
3
+$132K
4
Renaissance Technologies
Renaissance Technologies
New York
+$113K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$111K

Top Sellers

1
-$2.09M
2
-$855K
3
-$710K
4
IC
Ikarian Capital
Texas
-$197K
5
Two Sigma Investments
Two Sigma Investments
New York
-$160K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$31K
27
$29K
28
$29K
29
$29K
30
$16K
31
$6K
32
$4K
33
$1.15K
34
$1K
35
$1
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
1
2